Masters of Longevity - The Pulse

Fitt Insider - Press Releases18 Jun 2026
Eudēmonia Summit Announces Inaugural Advisory Board (Fitt Insider - Press Releases)

Eudēmonia Summit Announces Inaugural Advisory Board

A concise preview for curious attendees and industry professionals.

Key takeaways
  • Event announced its inaugural advisory board for scientific guidance and programming.
  • Board will focus on consumer health, well-being, and longevity themes.
  • Advisory members will influence future conference content and scientific agenda.
Longevity Technology18 Jun 2026
Forever chemicals may be aging you – longevity needs to wake up (Longevity Technology)

Forever chemicals may be aging you – longevity needs to wake up

An opinion arguing that longevity research and practice should prioritize removing environmental exposures as a core strategy alongside adding interventions.

Key takeaways
  • Founder of the largest authorized Berkey dealer in the US.
  • Walk into any longevity conference and you will hear about what to add.
  • Whole culture is built around inputs, the things you can buy and take.
Fight Aging!18 Jun 2026
AIAbility to Resist Mutational Damage in Fibroblast Cells Correlates with Species Life Span (Fight Aging!)

Ability to Resist Mutational Damage in Fibroblast Cells Correlates with Species Life Span

Examination of a comparative cellular study testing whether fibroblast mutation resistance across mammals relates to species-specific lifespan.

Key takeaways
  • Primary fibroblasts from ten mammalian species were exposed to low-dose ENU.
  • Excess single nucleotide variants were quantified using single-molecule sequencing.
  • Modest inverse correlation was found between ΔSNV burden and maximum lifespan.
MoL Event Pick
The Longevity Show 2026 (London, United Kingdom)

The Longevity Show 2026

26. JUN 2026 - 27. JUN 2026 - London, United KingdomExpo

The UK’s first longevity festival, helping you discover what really works for living healthier, longer. Testing, workouts, speakers & more.

Longevity Technology18 Jun 2026
World’s first in vivo gene editing Phase 3 win (Longevity Technology)

World’s first in vivo gene editing Phase 3 win

In vivo gene editing's recent clinical milestone is explored with upbeat analysis of its potential implications for genetic medicine and longevity.

Key takeaways
  • This is the first positive pivotal in vivo CRISPR Phase 3 clinical trial.
  • Treated patients experienced an 87% reduction in average monthly hereditary angioedema attacks.
  • No serious adverse events occurred and most side effects were mild or moderate.